Histological Variants—Plasmacytoid Bladder Cancer
Although plasmacytoid is a known aggressive variants of UC, plasmacytoid UC may be more aggressive (Makise et al. in Pathol Int 65(9):495–500, 2015). Serum CA19-9 could serve as a useful biomarker to monitor progression of plasmacytoid UC. This chapter covers diagnostics and management.
- Keck B, Wach S, Stoehr R, Kunath F, Bertz S, Lehmann J, Stöckle M, Taubert H, Wullich B, Hartmann A. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. BMC Cancer. 2013;8(13):71. https://doi.org/10.1186/1471-2407-13-71.CrossRefGoogle Scholar
- Raspollini MR, Sardi I, Giunti L, Di Lollo S, Baroni G, Stomaci N, Menghetti I, Franchi A. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series. Hum Pathol. 2011;42(8):1149–58.CrossRefGoogle Scholar